AVNR kept trading at 4 - 6 level for more than a year....Same story - PAR and the others supported by MMs which actually gives us same advantage to buy lower.
Oh, long ago I studied American literature in the University..... It looks like a beginning of a novel ... Please continue.
There was a speculative move up. Now it's a speculative move down accompanied by accumulation. That's all!
Sentiment: Strong Buy
Abstral and Zuplenz will add around $10 million of revenue per quarter to Gale in 2015. DO YOU MEAN PER YEAR? 50% revenue growth of 9 mln (2014) gives 15 mln max! Do not mislead investors too pls!
I don't know why everybody ignores that fact that UCB knew the ph3 results a year ago! When the ph3 was cancelled due to the lack of drug UCB still partial results from a couple of hundred patients. Do you think they would have started it again if they knew the results failed! Stick to your shares!
But it is good! Consider it an opportunity. When your well researched stock is manipulated down you know what to do.
Man. You must not rely on somebody's opinion or claims . Do your own research, listen to the presentations. Do not trust MB.